Nihon Nohyaku Co., Ltd. Stocks

¥ 1021Last Updated 10.04.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

¥ 508.93M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
¥ 1021
Key Takeaways

Risk factor

Considerable default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nihon Nohyaku Co., Ltd. researches, develops, and manufactures agrochemicals in Japan and internationally. The company offers fungicides, insecticides, and herbicides. It also provides chemical products for use in home gardening, greenery, and termite applications. In addition, it provides pharmaceuticals and animal health products, including topical anti-fungal agents, such as drugs for athlete's foot, as well as tick repellents for bees; and products for feed efficacy improvement; wood preservatives, and other agricultural materials; and landscape work, agrochemical residue analysis, and real estate rental services. Nihon Nohyaku Co., Ltd. was founded in 1926 and is headquartered in Tokyo, Japan. Nihon Nohyaku Co., Ltd. operates as a subsidiary of Adeka Corporation.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks